San Francisco, Oct 25 The
global bioinformatics
market is expected to reach USD 13.47 billion by 2020 growing at
an estimated CAGR of 21.2% from 2014 to 2020, according to a new report by
Grand View Research, Inc. Growing clinical development of biopharmaceutical and
increasing need for three dimensional drug designing technology are expected to
drive the market growth over the next five years.
Further
development of bioinformatics tools, platforms and analysis platforms coupled
with the introduction of novel technologies are expected to be high impact
rendering factors for the growth of this market. Increasing demand for faster
development of novel API and biopharmaceuticals is also expected to enhance the
growth of this industry.
Browse full research report on Bioinformatics Market:
www.grandviewresearch.com/industry-analysis/bioinformatics-industry
Growth
in the number of research and development studies in various ‘-omics’ related
segments and need for integration of the large amounts of biological data
generated from these studies is also expected to encourage industry players to
develop faster, more efficient and versatile bioinformatics software cum
platforms for commercialization.
Bio-content
processing accounted for over 47% of the revenue share in 2013. The presence of
increasing market demand for genetic databases management, and need for related
sequence, structural and phylogenic analysis tools and software is the primary
factor accounting for this large share.
Moreover,
the sequence and structural analysis platform segment is expected to grow at
the fastest CAGR of over 20% over the forecast period owing to the development
of next generation sequencing and expected reduction in cost of whole genome
exome sequencing. These factors are expected to have a significantly positive
impact on the overall growth of this market in the next five years.
Chemo-informatics
and genomics accounted for over 50% of revenue share in 2013. Growing demand
for novel biomarkers for R&D of biosimilar drugs and biopharmaceuticals is
expected to significantly enhance the market penetration over the forecast
period.
Browse more reports of this category
by Grand View Research: www.grandviewresearch.com/industry/healthcare-it
Proteomic
applications are expected to attract a considerable amount of R&D investment
in the near future and witness a lucrative growth over the forecast period.
Developments in three dimensional drug development technologies are further
expected to boost the growth of this segment.
North
America was observed to account for over 40% of the global revenue in 2013.
Factors accounting for this large share include the presence of large
pharmaceutical companies in the region, which are involved in the clinical
development of novel APIs and biosimilar drugs. The presence of a technologically
advanced healthcare R&D framework also enhances this region’s investment
capabilities for the development of the aforementioned market segments.
Asia
Pacific is expected to grow at the fastest CAGR over the forecast period owing
to the presence of companies providing outsourcing services to the industry for
larger eastern industry players. Furthermore, the presence of high unmet
industry need is also expected to be significant reason to impact the growth of
this region positively over the forecast period.
Key
players in this industry include IBM Life Sciences, BIOVIA, Life Technologies
Corporation, Agilent technologies, 3rdMillennium Inc., Celera
Corporation, Affymetrix, BioWisdom Ltd., and Rosetta Biosoftware.
Browse press release of this report
by Grand View Research: www.grandviewresearch.com/press-release/global-bioinformatics-market
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information:
www.grandviewresearch.com
No comments:
Post a Comment